Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript
Alkermes plc misses on earnings expectations. Reported EPS is $0.22 EPS, expectations were $0.46.
Alkermes Plc. (ALKS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 3,500,000 | $94,745,000 | -13% | 2.71% |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,069,840 | $28,960,569 | -9% | 0.26% |
| 3. | GLG Partners Noam Gottesman | 873,633 | $23,649,245 | -6% | 0.05% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 679,700 | $18,399,479 | -38% | 0.04% |
| 5. | Armistice Capital Steven Boyd | 672,218 | $18,196,941 | -44% | 0.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.31 | 35,000 | Director | 80,000 | 2022-11-14 | Filing | |
| $23.43 | 427 | Director | 9,366 | 2022-03-04 | Filing | |
| $30.22 | 1,650 | Director | 1,650 | 2021-08-23 | Filing | |
| $26.43 | 10,000 | Director | 10,000 | 2021-08-02 | Filing | |
| $19.65 | 6,940 | Director | 11,242 | 2020-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.10 | 10,417 | Officer | 65,911 | 2024-03-18 | Filing | |
| $29.65 | 2,559 | Officer | 7,717 | 2024-02-27 | Filing | |
| $31.85 | 2,690 | Director | 15,169 | 2024-02-15 | Filing | |
| $31.85 | 2,638 | Director | 7,479 | 2023-06-08 | Filing | |
| $31.50 | 2,800 | Director | 7,479 | 2023-06-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 30,022,427 | $832,822,125 | 0.02% | |
| 2. | 20,955,454 | $581,304,294 | 0.01% | |
| 3. | 15,241,470 | $422,798,379 | 0.07% | |
| 4. | 9,352,970 | $259,451,388 | 0.01% | |
| 5. | 5,476,255 | $151,911,314 | 4.87% |
News See All
5 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds.
12 Best Growth Stocks to Buy According to Billionaire Ray Dalio's Bridgewater Associates
In this piece, we will take a look at the 12 best growth stocks to buy according to billionaire Ray Dalio's Bridgewater Associates.
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
In this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons' stock portfolio.
5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
Below we present the list of 5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Alkermes plc (NASDAQ:ALKS) Q3 2023 Earnings Call Transcript
Operator: Greetings. And welcome to the Alkermes Third Quarter 2023 Financial Results Conference Call. My name is Donna and I’ll be your operator for today’s call.
Alkermes plc (NASDAQ:ALKS) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Alkermes Second Quarter 2023 Earnings Financial Results Conference Call. My name is Marianne, I’ll be your operator for today’s call.
Hedge Fund and Insider Trading News: Ken Griffin, Crispin Odey, Joel Greenblatt, Ancora Advisors, Sarissa Capital, Elliott Management, Clene Inc. (CLNN), Asana, Inc. (ASAN), and More
Proxy advisory firm Institutional Investor Services urged Alkermes (ALKS.O) shareholders to elect one of three director candidates proposed by activist hedge fund Sarissa Capital, arguing more outside...
Hedge Fund and Insider Trading News: Ken Griffin, Sarissa Capital, Odey Asset Management, Balyasny Asset Management, Three Arrows Capital, Altus Power Inc (AMPS), ACI Worldwide, Inc. (ACIW), and More
Ken Griffin, whose hedge fund churned out a record $16 billion for clients last year, is increasing his focus on credit trading as he braces for a potential US recession.
Alkermes plc (NASDAQ:ALKS) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Alkermes First Quarter 2023 Financial Results Conference Call. My name is Rob and I'll be your operator for today's call.
Billionaire Hedge Funds
